Grants per year
Personal profile
Research Interests
My clinical domain is breast cancer management. My clinical research interest focuses on the development of novel therapies for the treatment of breast cancer. Clinical trials focusing on precision medicine for defining the right therapy, for the right patient at the right time is our goal. To that end, molecular interogation of breast tumors are leading to novel trial design that will hopefully translate into better outcomes for our patients. In conjuction with the developmental therapeutics program, novel agents are being incorporated into clinical trials for patients with both early and late stage disease.
Certifications and Licenses
| Internal Medicine | |
| Medical Oncology |
Training Experience
| 1986 | Residency, Michael Reese Medical Center |
| 1990 | Fellowship, University of Chicago Hospitals |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, MD, University of Illinois at Chicago
… → 1982
Research interests
- Breast Cancer
- Chemotherapy
- Clinical Research
- Drug Discovery
- Drugs (clinical pharmacology)
- Genomic Medicine/Personalized Medicine
- Medical Education
Fingerprint
Dive into the research topics where William J Gradishar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #CT7001_001: A Modular, Multipart, Multi-arm, Open-label, Phase 1/2a Study to Evaluate the Safety and Tolerability of CT7001 Alone and in Combination with Anti-Cancer Treatments in Patients with Advanced Malignancies
Emas Pharma Limited, Carrick Therapeutics Ltd
10/15/20 → 10/15/23
Project: Research project
-
Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysis
Weiser, R., Polychronopoulou, E., Hatch, S. S., Haque, W., Ghani, H. A., He, J., Kuo, Y. F., Gradishar, W. J. & Klimberg, V. S., May 1 2022, In: Cancer. 128, 9, p. 1738-1747 10 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
A spotlight on avoidance coping to manage fear of recurrence among breast cancer survivors in an eHealth intervention
Hall, D. L., Levine, B. J., Jeter, E., Chandler, A., Tooze, J. A., Duffecy, J., Victorson, D., Gradishar, W., Leach, J., Saphner, T., Smith, M. L., Penedo, F., Mohr, D. C., Cella, D. & Wagner, L. I., Oct 2022, In: Journal of Behavioral Medicine. 45, 5, p. 771-781 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Breast Cancer, Version 3.2022
Gradishar, W. J., Moran, M. S., Abraham, J., Aft, R., Agnese, D., Allison, K. H., Anderson, B., Burstein, H. J., Chew, H., Dang, C., Elias, A. D., Giordano, S. H., Goetz, M. P., Goldstein, L. J., Hurvitz, S. A., Isakoff, S. J., Jankowitz, R. C., Javid, S. H., Krishnamurthy, J., Leitch, M., & 17 others, Jun 2022, In: JNCCN Journal of the National Comprehensive Cancer Network. 20, 6, p. 691-722 32 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Ductal Carcinoma In Situ of Breast: From Molecular Etiology to Therapeutic Management
Hophan, S. L., Odnokoz, O., Liu, H., Luo, Y., Khan, S., Gradishar, W., Zhou, Z., Badve, S., Torres, M. A. & Wan, Y., Apr 1 2022, In: Endocrinology (United States). 163, 4, bqac027.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
NCCN Guidelines Updates: Management of Patients With HER2-Negative Breast Cancer
Gradishar, W. J., Jun 2022, In: JNCCN Journal of the National Comprehensive Cancer Network. 20, 55, p. 561-565 5 p.Research output: Contribution to journal › Article › peer-review
Open Access